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Background
cGMP is synthesized via nitric oxide- or natriuretic pep-
tide-stimulated guanylyl cyclases and exhibits pleiotropic
regulatory functions also in the kidney. Hence, the inte-
gration of cGMP signaling via cGMP-dependent protein
kinases (cGK) might play a critical role for renal phy-
siology. Both isozymes were detected in arterioles,
mesangium and within the cortical interstitium. In con-
trast to cGKIa,t h eb isoform was not detected in the
juxtaglomerular apparatus and medullary fibroblasts.
Results
Here, we examined the function of cGKI in the renal
interstitium emphasizing a functional differentiation of
both isoforms. The interstitium exists mainly of fibro-
blasts playing a prominent role in the interstitial fibrosis.
Accordingly, cGKI could also be involved in this patho-
physiological process. Therefore, we studied whether
cGKI influences renal fibrosis by application of cGMP
increasing YC-1 or ISDN and by using mutant mice.
The kidney-fibrosis was induced by unilateral ureter
obstruction (UUO).
Conclusion
Administration of ISDN showed significantly antifibrotic
effects in wt- but not in aSM-rescue mice. Also tg-tg
mice which express more cGKIa developed significantly
less fibrosis than wt mice. Moreover, mRNA- and pro-
tein expression of cGKIb was fewer influenced by fibro-
sis than cGKIa. Accordingly, our results indicate that
cGMP acts primarily via cGKIa as an important sup-
pressor of kidney fibrosis.
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